Published in Medical Letter on the CDC and FDA, November 16th, 2003
"The regulatory clearance of the interpretation and measurement algorithms clears the way for us to bring our proven resting electrocardiogram (ECG) product line into the U.S. market. Our personal computer (PC)-based and mobile hand-held 12-lead ECG devices are widely used in Europe and we have been waiting for this moment since the merger of Del Mar Medical with Reynolds Medical in January," said Raphael Henkin, PhD, president of Del Mar Reynolds Medical,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.